Psoriatic arthritis risk in psoriasis patients receiving anti-IL-23 <i>vs</i> anti-IL-17: comparison of drug classes and individual agents
PsO patients treated with IL23i had a lower subsequent PsA risk compared with those treated with IL17i.
Authors
- Teng‐Li Lin (ORCID: https://orcid.org/0000-0002-0639-3533)
- Chun‐Ying Wu (ORCID: https://orcid.org/0000-0001-5053-1801)
- Chao-Kuei Juan
- Yi‐Hsuan Fan
- Kuo-Sheng Fan
Institutions
- National Yang Ming Chiao Tung University (TW)
- National Chung Hsing University (TW)
- China Medical University (TW)
- Taipei Veterans General Hospital (TW)
- Taichung Veterans General Hospital (TW)
- Chung Shan Medical University Hospital (TW)
- Buddhist Tzu Chi Medical Foundation (US)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2025-10-16
- DOI
- https://doi.org/10.1093/rheumatology/keaf489
- Citations
- 2
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 1.59